Advertisements

Cirizine

Quick links to important sections

Cirizine

Advertisements

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Cirizine

What is Cirizine? An Overview of Identity and Class

Property Description
Active Ingredient Cetirizine Hydrochloride
Form Tablet, Oral Solution, Syrup
Pharmacological Class H1-Receptor Antagonist (Antihistamine)
Origin Synthetic (Second-Generation Derivative)

Cirizine is a synthetic pharmaceutical agent whose primary constituent is the active ingredient Cetirizine Hydrochloride. It is scientifically classified within the pharmacological class of H1-receptor antagonists (antihistamines), a category established within pharmacology. This means the drug works by interfering with the body's allergic response mechanisms. Chemically, Cetirizine is designated as a second-generation piperazine derivative, a classification reflecting its key feature: a high degree of peripheral selectivity. This structure ensures the drug primarily targets histamine receptors outside the central nervous system. The core purpose of this focused action is to provide relief from general allergy-related discomfort, such as when exposed to seasonal environmental triggers, while minimizing the potential for sedation associated with older antihistamine types.


Cetirizine Hydrochloride: Composition and General Purpose

Cirizine is formulated as a single-ingredient product, containing the substance Cetirizine Hydrochloride. It is available in several dosage forms, including the conventional solid tablet and the liquid oral solution or syrup. All forms are intended for the oral route of administration. The mechanism of action involves the inhibition of histamine effects, stabilizing the body’s reaction to irritants. By interrupting this chemical cascade, the drug's general therapeutic purpose is to provide symptomatic relief and lessen the body's overreaction to environmental factors. Cetirizine is recognized as an essential medicine, a status that confirms the drug's established role as a foundational tool for allergy management.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. Cetirizine on the eEML
Advertisements

What side effects are possible with Cirizine?

Possible Side Effects and Safety Information

The safety profile of Cirizine (Cetirizine Hydrochloride) is officially documented by regulatory authorities, classifying possible adverse reactions by the frequency observed in clinical studies and post-marketing surveillance. This information structures the understanding of the medicine’s risk profile, focusing on documented effects and specific constraints.


Frequency-Classified Adverse Reactions

The most frequently reported effects are classified as Common (affecting 1 to 10 users in 100) and include somnolence (drowsiness), headache, fatigue, dry mouth (xerostomia), and dizziness. Effects classified as Uncommon include agitation, nausea, and abdominal pain. Rare adverse reactions include convulsions, tachycardia (rapid heart rate), and hepatic function abnormal (changes in liver enzyme levels).


System-Organ Class Involvement

The documented adverse effects are grouped according to the physiological system they affect. The primary categories involved are Nervous System Disorders (e.g., somnolence, headache), Gastrointestinal Disorders (e.g., dry mouth, nausea), and General Disorders (e.g., fatigue, swelling). Rare but serious reactions, such as anaphylactic shock, are categorized under Immune System Disorders.


Specific Safety Considerations and Restrictions

Regulatory documents include specific safety constraints for certain populations and usage contexts. Use is restricted in individuals with severe renal impairment (severe kidney disease). The official labeling also notes that patients with renal impairment or older adults may require specific attention due to potential changes in drug clearance. Additionally, the label advises that the medication may cause added impairment of central nervous system performance when used concurrently with alcohol or other CNS depressants. Rarely, discontinuation of long-term use has been associated with the development of intense pruritus (itching) or urticaria (hives).

Advertisements

Overdose and Emergency Response

The official overdose profile for Cirizine, based on authoritative regulatory documents (EMA/FDA), mandates immediate action when an excess amount is taken. Suspected overdose requires individuals to seek immediate medical attention or contact a Poison Control Center right away.

Documented manifestations are typically reported following the ingestion of at least five times the recommended daily dose. These presentations primarily affect the Central Nervous System, including somnolence, sedation, confusion, dizziness, and severe signs like stupor. Systemic and anticholinergic-like effects, such as tachycardia (rapid heartbeat), urinary retention, and mydriasis (pupil dilation), have also been reported.

Overdose in pediatric patients may present with an initial phase of excitement or agitation prior to the onset of drowsiness. Management focuses strictly on supportive care, as no specific antidote is known to cetirizine. Treatment may involve procedures such as gastric lavage or the administration of activated charcoal. Due to the risk of cardiac involvement, monitoring of cardiac function (ECG) may be required as part of the management protocol.

Advertisements

Therapeutic Uses of Cirizine

Main Uses and Benefits of Cirizine

Cirizine is a second-generation antihistamine used to manage symptoms associated with various allergic conditions. It works by blocking the effects of histamine, a natural substance in the body that causes allergic reactions.

Relief of Respiratory Allergy Symptoms

Cirizine is primarily used to address symptoms of allergic rhinitis, commonly known as hay fever. This includes both seasonal allergies and year-round (perennial) allergies. It helps reduce the following symptoms:

  • Sneezing: Minimizes the frequency and intensity of sneezing fits.
  • Runny Nose: Reduces nasal discharge and congestion.
  • Itchy Nose and Throat: Relieves the irritation often associated with inhaled allergens like pollen, dust mites, or pet dander.
  • Watery, Itchy Eyes: Addresses allergic conjunctivitis symptoms, helping to soothe redness and irritation in the eyes.

Management of Skin Conditions

Beyond respiratory symptoms, Cirizine is used in the treatment of skin-related allergic reactions. Its primary application in this area is for chronic idiopathic urticaria, also known as hives.

  • Itching (Pruritus): Helps alleviate the persistent itching caused by hives.
  • Skin Rashes: Reduces the appearance and discomfort of raised, red welts on the skin.

Benefits of Second-Generation Antihistamines

As a second-generation antihistamine, Cirizine offers specific functional advantages in the management of daily symptoms:

  • Extended Duration: The effects typically last for a significant period, often allowing for once-daily management of symptoms.
  • Reduced Sedation: Compared to first-generation antihistamines, Cirizine is designed to have a lower likelihood of crossing the blood-brain barrier, which generally results in less drowsiness for many users, though individual responses may vary.
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Official regulatory documents define specific populations who are eligible to use cetirizine (sometimes referred to as Cirizine) and those who must not use it. Eligibility is strictly determined by age, medical history, and organ function.


Contraindicated Populations (Must Not Use)

Classification Condition/Group
Hypersensitivity Known allergy to cetirizine, its derivative hydroxyzine, or any related piperazine compounds.
Severe Renal Impairment Patients with end-stage renal disease or severe kidney failure (creatinine clearance <10 mL/min).

Age-Related Eligibility

Use is contraindicated for children under 6 years of age for most tablet formulations. Younger children (e.g., as young as 6 months) may be eligible for oral solution under medical guidance, though this use is not established in all regions for all indications.


Restricted Use (Requires Dose Adjustment or Special Consideration)

Patients with moderate to severe renal impairment must use a lower dose determined by a healthcare provider. Use also requires caution in the elderly due to a higher likelihood of reduced kidney function, and in patients with a predisposition to urinary retention (e.g., prostatic hyperplasia) or those prone to convulsions.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines interaction patterns for Cirizine (Cetirizine Hydrochloride) based strictly on official regulatory prescribing information.

Documented Pharmacodynamic and Substance Interactions

Category Interacting Entities Official Regulatory Description
Pharmacodynamic Interaction Central Nervous System (CNS) Depressants (e.g., sedatives, tranquilizers) Potential for additive effects resulting in increased impairment of mental alertness or drowsiness.
Substance Interaction Alcohol Potential for additive reduction in alertness and increased impairment of performance.

Documented Pharmacokinetic Interactions

Category Interacting Entity Official Regulatory Description
Exposure Modification Theophylline (at a high daily dose 400 mg) Co-administration resulted in a small 16% decrease in Cetirizine clearance, which may increase systemic exposure to Cirizine.

Regulatory Constraints and Profile

Official regulatory documents do not list any substances as formally contraindicated for co-administration with Cirizine based on interaction risk. Furthermore, the official labeling does not specify mandatory separation windows or timing rules for co-administering Cirizine with other medicinal products. The documented interactions are confined to additive CNS effects and a single, low-level pharmacokinetic alteration, reflecting the drug's limited interaction profile as defined by government regulators.

Advertisements

Mechanism of Action

How Cetirizine Works

Cetirizine is classified as a second-generation antihistamine, exerting its primary pharmacodynamic effect through selective antagonism of peripheral Histamine H1 receptors (H1R) .

Molecular Interaction and Pathway Modulation

Following administration, Cetirizine demonstrates high affinity for H1 receptors located on various cell types, including vascular endothelial cells and smooth muscle cells, predominantly outside the central nervous system. By acting as a competitive antagonist, Cetirizine occupies the H1 binding sites, preventing the interaction of endogenous histamine with the receptor. Histamine is an amine released from mast cells and basophils, which, upon binding to the H1R, initiates a Gq-protein coupled signaling cascade involving phospholipase C and intracellular calcium release.

Downstream Physiological Consequence

By blocking H1R activation, Cetirizine interrupts this histamine-mediated signaling pathway. This inhibition modulates subsequent cellular responses such as the increased microvascular permeability and vasodilation typically triggered by histamine release. Additionally, Cetirizine exhibits H1R-independent activity by inhibiting the migration of inflammatory cells, including eosinophils and neutrophils, to sites of inflammation, and by regulating the release of certain cytokines and chemokines. The compound’s physicochemical properties, particularly its hydrophilicity, limit its ability to cross the blood-brain barrier, resulting in selective targeting of peripheral H1 receptors.

Advertisements

Dosage and Administration Information

How to Use Cirizine

Cirizine (Cetirizine Hydrochloride) is administered via the oral route as tablets or an oral solution, which are the standard forms for general use. An intravenous injection is also an approved route for the acute management of specific conditions in some jurisdictions, requiring administration in a clinical setting.

Standard Dosing and Schedule

The typical standard oral dose for adults and adolescents (age 12 and older) is 10 mg, taken once daily. The maximum recommended oral dose is established as 10 mg in a 24-hour period. The medication may be taken with or without food, offering flexibility in daily scheduling. Tablets should be swallowed whole with liquid.

Population-Specific Instructions

Dose adjustments are required for specific patient groups. For children aged 6 to 12 years, the dose is commonly divided into 5 mg taken twice daily. Furthermore, the standard dosing interval must be modified in adults with impaired renal function. This often requires a reduced daily dose or an extension of the interval between doses, based on the degree of kidney function, to prevent over-exposure. The tablet form is not recommended for children under 6 as it does not allow for necessary dose precision. If a dose is missed, patients are advised not to take a double dose to make up for the forgotten dose.

Advertisements

Recent Clinical Evidence

Research examined conditions like allergic rhinitis (hay fever) and chronic urticaria (hives) primarily through short-term randomized controlled trials (RCTs). These studies evaluated changes in patient-reported outcomes, such as overall symptom scores (TSS) for nasal and ocular discomfort and objective wheal (hive) counts. Findings describe patterns where measured differences were recorded in symptom scores across adult and pediatric populations.

Comparative research reported that the measured outcomes were similar to those observed with other established treatments, and the compound is frequently included as an active comparator in ongoing trials. Studies have also evaluated the compound for allergic conjunctivitis. Research used specialized trials, including the controlled allergen challenge model, to monitor outcomes linked to inflammatory states, focusing mainly on severe ocular itching. Studies reported how measured outcomes changed rapidly following allergen exposure, with findings observed within the immediate term and over defined short intervals.

The research landscape shows areas where evidence remains limited. A consistent factor across all indications is the duration of follow-up; research on long-term effects remains incomplete in controlled settings. Data for certain groups, particularly very young children (infants under 2 years), is limited, as findings often rely on extrapolation rather than dedicated efficacy trials. Furthermore, the reliance on acute allergen challenge models in ocular research means those results may not fully reflect natural-season patterns. Comparative evidence against a wide array of alternative treatments is also limited in scope.

Key Studies & References

  1. H1-antihistamines for chronic spontaneous urticaria: an abridged Cochrane Systematic Review
  2. Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Cirizine (FAQ)


Q: Can Cirizine affect my driving ability?

Official product information states that Cirizine may cause somnolence, which is the medical term for drowsiness, and may temporarily impair your ability to drive or operate machinery. Regulatory warnings indicate that concurrent use with alcohol or other Central Nervous System (CNS) depressants may result in increased impairment of alertness.


Q: What is the difference between Cirizine and other common allergy medicines (in general terms)?

Cirizine, whose active ingredient is cetirizine, is scientifically classified as a second-generation H1-receptor antagonist, also known as an antihistamine. This classification indicates that the compound is designed to target histamine receptors primarily outside the brain, which generally suggests a lower likelihood of sedation compared to older, first-generation antihistamines.


Q: Is Cirizine related to or in the same drug class as Claritin?

Studies and official information indicate that the active ingredient in Cirizine is in the same general pharmacological class as Claritin (loratadine). Both are categorized by health authorities as second-generation antihistamines, which are compounds used to manage allergy symptoms.


Q: What conditions besides allergies is Cirizine sometimes used for, according to regulatory documents?

Beyond common allergic rhinitis (hay fever), regulatory documents indicate that Cirizine is approved for the relief of symptoms associated with chronic idiopathic urticaria, which is the medical term for long-lasting hives of unknown cause. Regulatory documents indicate this use applies to adults and paediatric patients in specified age ranges.


Q: Does Cirizine interact with common antidepressants?

Official regulatory information advises caution when using Cirizine with Central Nervous System (CNS) depressants, which is a broad category that may include certain types of antidepressants. This is because combining them may lead to additive effects, potentially resulting in increased drowsiness or impaired alertness.


Q: Are there specific times of day when Cirizine is typically taken?

The standard administration guideline for adults and adolescents is to take the medicine once daily. While the guidance does not mandate a specific time of day (morning versus night), the standard is a once-daily administration.


Q: What is the approved age range for Cirizine use?

The approved age of use varies by formulation. The oral solution is typically indicated for paediatric patients 2 years and above for certain conditions. Tablet formulations are generally for patients 6 years and above, and the product is generally not recommended for use in children under 2 years of age.


Q: Is Cirizine effective for all types of seasonal allergies?

Regulatory documents specify the drug's approved uses. Cirizine is indicated for managing the nasal and ocular symptoms associated with seasonal allergic rhinitis (hay fever) as well as perennial allergic rhinitis (year-round allergies).


Q: Is Cirizine considered a long-term medicine?

Post-marketing experience reports have documented cases of patients who used Cirizine long-term. In rare instances, discontinuation after such use has been associated with symptoms like intense itchiness (pruritus).


Q: How quickly can I expect Cirizine to start working?

According to pharmacokinetic data, the medicine is rapidly absorbed after being taken orally. The time needed to reach the maximum concentration in the blood, known as Tmax, is generally around 1 hour for adults.


Q: Are there different strengths of Cirizine available?

Official prescribing information confirms that Cirizine is available in different product strengths and forms. These typically include oral tablets in both 5 mg and 10 mg strengths, in addition to liquid forms like an oral solution.


Q: Does taking Cirizine require a prescription in all countries?

In the United States, Cirizine's active ingredient, cetirizine, is approved for sale as an Over-the-Counter (OTC) medicine, meaning a prescription is not required. However, the legal and regulatory status of this medicine can vary by country.


Q: How long does the effect of one dose of Cirizine typically last?

Pharmacokinetic data shows that the plasma elimination half-life—the time it takes for half the medicine to be cleared from the body—is approximately 8.3 hours in adults. Consistent with its intended daily use, many product labels are based on studies supporting 24-hour relief of symptoms.


Q: What does official guidance say about Cirizine use during pregnancy?

Cirizine was previously classified by the US FDA as a Pregnancy Category B medicine. Regulatory guidelines indicate that its use during pregnancy is typically reserved for situations when it is considered clearly necessary.


Q: Can I take Cirizine if I am breastfeeding?

Official product labeling often indicates that the use of this medicine is not recommended while breastfeeding. This information is based on the potential risks and benefits documented for the nursing infant.


Q: What are the signs of taking too much Cirizine?

Symptoms reported following an overdose are primarily linked to effects on the central nervous system. These may include signs such as confusion, dizziness, fatigue, restlessness, pronounced drowsiness (somnolence), or a rapid heartbeat.


Q: Is Cirizine known to cause weight gain?

According to the list of officially documented adverse reactions, weight increased is categorized as a rare undesirable effect. This means it has been reported in post-marketing surveillance or clinical studies, though not frequently.


Q: Does the effectiveness of Cirizine decrease over time with regular use?

Studies examining the antihistaminic effect have suggested that there was no tolerance developed to the medicine after a defined period of regular use in paediatric patients. This information suggests that the effectiveness did not diminish during the specific period measured in those studies.


Q: What should I do if a side effect of Cirizine bothers me greatly?

Official guidance emphasizes the importance of contacting a healthcare provider if any side effect becomes severe, worsens over time, or causes great concern. This is especially important if there is suspicion of an allergic reaction or overdose.


Q: Is there a generic version of Cirizine available?

Yes, the active ingredient in Cirizine, cetirizine hydrochloride, is available in a generic version. Regulatory agencies like the FDA approved the generic form for use in 2008.


Q: What is the difference between the brand name and the generic Cirizine?

Regulatory bodies confirm that the generic version is required to contain the exact same active ingredient as the brand name product. Furthermore, the generic must be bioequivalent, meaning it is expected to work in the same way in the body.


Q: What precautions are listed for patients with certain pre-existing eye conditions when using Cirizine?

Post-marketing surveillance reports have noted isolated cases of eye accommodation disorders in users. This is recognized as a potential anticholinergic effect of the drug's class.


Q: Can Cirizine be purchased over-the-counter in some regions?

Yes, the medicine's active ingredient is approved for Over-the-Counter (OTC) sale in the United States and is similarly available in many other regions globally.

Advertisements

How should Cirizine be stored and disposed of?

How to Store and Dispose of Cetirizine?

Storage Requirements

Cetirizine must be stored at room temperature, and it is essential to keep the medication away from excess heat and moisture, such as in the bathroom. The medicine should remain in its original, tightly closed container and protected away from light. To prevent accidental exposure, the medication must be kept out of the sight and reach of children by using a safety-capped container and placing it in a secure, high location.

Disposal Instructions

For disposal of unused or expired Cetirizine, the preferred option is to use a community drug take-back program or mail-back envelope immediately. If a take-back program is unavailable, the product should be removed from its container, mixed with an undesirable substance (like dirt or used coffee grounds), and placed in a sealed container before being thrown into the household trash. Cetirizine is not on the FDA's flush list and should not be disposed of by flushing it down a toilet or emptying it into a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cirizine found in:

A-Z Index: